Showing results (1391-1400 of 3,083) with videos related to
Sort By:
Pageof 309
Drug Safety|December 26, 2014
The US Food and Drug Administration-European Medicines Agency collaboration in pharmacovigilance: common objectives and common challengesGerald J Dal Pan, Peter R ArlettDrug Safety|December 25, 2014
Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trialElena Lopez-Gonzalez, Maria T Herdeiro, María Piñeiro-Lamas, et al.Drug Safety|November 14, 2015
Mortality Risk of Hypnotics: Strengths and Limits of EvidenceDaniel F KripkeDrug Safety|July 10, 2014
Zoo or savannah? Choice of training ground for evidence-based pharmacovigilanceG Niklas Norén, Ola Caster, Kristina Juhlin, et al.Drug Safety|August 16, 2014
Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder: an updateGariba A H Awudu, Frank M C BesagDrug Safety|October 9, 2014
Benefits and risks of using smart pumps to reduce medication error rates: a systematic reviewKumiko Ohashi, Olivia Dalleur, Patricia C Dykes, et al.Drug Safety|October 30, 2014
Liver safety assessment: required data elements and best practices for data collection and standardization in clinical trialsMark I Avigan, Einar S Bjornsson, Markku Pasanen, et al.Drug Safety|October 30, 2014
Liver safety assessment in special populations (hepatitis B, C, and oncology trials)Gerd A Kullak-Ublick, Michael Merz, Louis Griffel, et al.Drug Safety|October 19, 2017
Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced Non-small-Cell Lung Cancer (JO25567): Updated Safety ResultsTerufumi Kato, Takashi Seto, Makoto Nishio, et al.Drug Safety|February 7, 2018
Drug-Induced Ototoxicity: Diagnosis and MonitoringKathleen C M Campbell, Colleen G Le PrellPageof 309